Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation

Kathleen M. Sakamoto(Howard Hughes Medical Institute), Kyung B. Kim(Howard Hughes Medical Institute), Akiko Kumagai(Howard Hughes Medical Institute), Frank Mercurio(Howard Hughes Medical Institute), Craig M. Crews(Howard Hughes Medical Institute), Raymond J. Deshaies(Howard Hughes Medical Institute)
Proceedings of the National Academy of Sciences
July 3, 2001
Cited by 2,424Open Access
Full Text

Abstract

The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis. One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex containing Hrt1 (SCF). We sought to artificially target a protein to the SCF complex for ubiquitination and degradation. To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin. A chimeric compound, protein-targeting chimeric molecule 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF. One domain of Protac-1 contains the I kappa B alpha phosphopeptide that is recognized by the F-box protein beta-TRCP, whereas the other domain is composed of ovalicin. We show that MetAP-2 can be tethered to SCF(beta-TRCP), ubiquitinated, and degraded in a Protac-1-dependent manner. In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.


Related Papers

No related papers found

Powered by citation graph analysis